{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:26:53Z","timestamp":1788848813876,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.cyto.2021.155521","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T10:28:33Z","timestamp":1620469713000},"page":"155521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Cytokine profile in patients with chronic non-bacterial osteomyelitis, juvenile idiopathic arthritis, and insulin-dependent diabetes mellitus"],"prefix":"10.1016","volume":"143","author":[{"given":"Mikhail M.","family":"Kostik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Makhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei S.","family":"Maletin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamai M.","family":"Magomedova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lybov S.","family":"Sorokina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Tsukasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takayanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy S.","family":"Vasiliev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darya I.","family":"Kozlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Yu.","family":"Mushkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cyto.2021.155521_b0005","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s10875-013-9902-5","article-title":"Chronic recurrent multifocal osteomyelitis","volume":"33","author":"Costa-Reis","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cyto.2021.155521_b0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12969-018-0290-5","article-title":"Chronic non-bacterial osteitis - a multicentre study","volume":"16","author":"Bhat","year":"2018","journal-title":"Pediatr. Rheumatol."},{"issue":"23","key":"10.1016\/j.cyto.2021.155521_b0015","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.cyto.2021.155521_b0020","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/rheumatology\/kex306","article-title":"Bone involvement in monogenic autoinflammatory syndromes","volume":"57","author":"Bader-Meunier","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2021.155521_b0025","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s11914-017-0405-9","article-title":"Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, pathogenesis, and treatment","volume":"15","author":"Hofmann","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"issue":"7","key":"10.1016\/j.cyto.2021.155521_b0030","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/rheumatology\/key058","article-title":"The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry","volume":"57","author":"Girschick","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.cyto.2021.155521_b0035","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clim.2015.09.013","article-title":"Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1beta expression and release","volume":"161","author":"Hofmann","year":"2015","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155521_b0040","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11926-012-0239-5","article-title":"Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis","volume":"14","author":"Ferguson","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"issue":"8","key":"10.1016\/j.cyto.2021.155521_b0045","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/acr.23462","volume":"70","author":"Zhao","year":"2018","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"5","key":"10.1016\/j.cyto.2021.155521_b0050","doi-asserted-by":"crossref","first-page":"e1190","DOI":"10.1542\/peds.2011-3788","article-title":"Pediatric chronic non-bacterial osteomyelitis","volume":"130","author":"Borzutzky","year":"2012","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.cyto.2021.155521_b0055","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/rheumatology\/kel190","article-title":"Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients","volume":"46","author":"Jansson","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.cyto.2021.155521_b0060","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155521_b0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1546-0096-11-47","article-title":"Autoinflammatory bone disorders with a special focus on chronic recurrent multifocal osteomyelitis (CRMO)","volume":"11","author":"Hofmann","year":"2013","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"4","key":"10.1016\/j.cyto.2021.155521_b0070","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.rdc.2013.05.002","article-title":"Autoinflammatory bone diseases","volume":"39","author":"Stern","year":"2013","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"6","key":"10.1016\/j.cyto.2021.155521_b0075","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00296-016-3466-7","article-title":"Serum biomarkers for the diagnosis and monitoring of chronic recurrent multifocal osteomyelitis (CRMO)","volume":"36","author":"Hofmann","year":"2016","journal-title":"Rheumatol. Int."},{"issue":"10","key":"10.1016\/j.cyto.2021.155521_b0080","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41584-019-0277-8","article-title":"The IL-1 family of cytokines and receptors in rheumatic diseases","volume":"15","author":"Dinarello","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"11","key":"10.1016\/j.cyto.2021.155521_b0085","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41584-018-0091-8","article-title":"Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis","volume":"14","author":"Gravallese","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155521_b0090","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis","volume":"55","author":"Chiricozzi","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2021.155521_b0095","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/annrheumdis-2014-205351","volume":"74","author":"Brunner","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.cyto.2021.155521_b0100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/annrheumdis-2012-201818","article-title":"Efficacy of anti-IL-1 treatment in Majeed syndrome","volume":"72","author":"Herlin","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2021.155521_b0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1546-0096-9-2","article-title":"Glucocorticoid receptor gene polymorphism and juvenile idiopathic arthritis","volume":"9","author":"Kostik","year":"2011","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"1","key":"10.1016\/j.cyto.2021.155521_b0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids: Mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"7","key":"10.1016\/j.cyto.2021.155521_b0115","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1210\/en.2004-1455","article-title":"Role of -3 eta as a positive regulator of the glucocorticoid receptor transcriptional activation","volume":"146","author":"Kim","year":"2005","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.cyto.2021.155521_b0120","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/rheumatology\/kez317","article-title":"Mutation in IL36RN impairs the processing and regulatory function of the interleukin-36-receptor antagonist and is associated with DITRA syndrome","volume":"59","author":"Roy","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.cyto.2021.155521_b0125","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/exd.13387","volume":"28","author":"Bal","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.cyto.2021.155521_b0130","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3389\/fimmu.2018.00763","article-title":"Unique action of Interleukin-18 on T cells and other immune cells","volume":"9","author":"Nakanishi","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155521_b0135","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/ijms20030649","article-title":"Interleukin-18 in Health and Disease","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cyto.2021.155521_b0140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2249.2004.02475.x","article-title":"Interleukin-18 as a potential target in inflammatory arthritis","volume":"136","author":"Gracie","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155521_b0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/1529-0131(200001)43:1<109::AID-ANR14>3.0.CO;2-3","article-title":"Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term","volume":"43","author":"Vittecoq","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cyto.2021.155521_b0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00296-019-04479-2","article-title":"The peculiarities and treatment outcomes of the spinal form of chronic non-bacterial osteomyelitis in children: a retrospective cohort study","volume":"40","author":"Kostik","year":"2020","journal-title":"Rheumatol. Int."},{"issue":"6","key":"10.1016\/j.cyto.2021.155521_b0155","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jbspin.2017.07.003","article-title":"Clinical predictors of magnetic resonance imaging-detected sacroiliitis in children with enthesitis-related arthritis","volume":"84","author":"Bou Antoun","year":"2017","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.cyto.2021.155521_b0160","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/art.40727","volume":"71","author":"Hinze","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.cyto.2021.155521_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072138","article-title":"S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-\u03baB(1)","volume":"8","author":"Simard","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cyto.2021.155521_b0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/00365521.2018.1447597","article-title":"Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies","volume":"53","author":"Ahluwalia","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155521_b0175","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155521_b0180","doi-asserted-by":"crossref","first-page":"102429","DOI":"10.1016\/j.autrev.2019.102429","article-title":"Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies","volume":"19","author":"Ruiz de Morales","year":"2020","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.cyto.2021.155521_b0185","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2217\/bmm-2017-0082","article-title":"Serum TNF-alpha, erythrocyte sedimentation rate and IL-6 are more valuable biomarkers for the assisted diagnosis of chronic extremity osteomyelitis","volume":"11","author":"Jiang","year":"2017","journal-title":"Biomark. Med."},{"issue":"42","key":"10.1016\/j.cyto.2021.155521_b0190","doi-asserted-by":"crossref","first-page":"e1874","DOI":"10.1097\/MD.0000000000001874","article-title":"Clinical characteristics and treatment of extremity chronic osteomyelitis in Southern China: A retrospective analysis of 394 consecutive patients","volume":"94","author":"Jiang","year":"2015","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.cyto.2021.155521_b0195","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluid from patients with rheumatoid arthritis was a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2021.155521_b0200","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1359\/jbmr.1999.14.9.1513","article-title":"Interleukin-17: A new bone acting cytokine in vitro","volume":"14","author":"Van Bezooijen","year":"1999","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.cyto.2021.155521_b0205","first-page":"4743","article-title":"Interleukin17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages","volume":"19","author":"Song","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cyto.2021.155521_b0210","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2021.155521_b0215","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/cdd.2009.74","article-title":"IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodelling","volume":"16","author":"Huang","year":"2009","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.cyto.2021.155521_b0220","first-page":"866","article-title":"Dynamic visualization of RANKL and Th17-mediated osteoclast function","volume":"123","author":"Kikuta","year":"2013","journal-title":"Clin. Invest."},{"key":"10.1016\/j.cyto.2021.155521_b0225","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/art.21342","article-title":"Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases-3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis","volume":"52","author":"Koenders","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2021.155521_b0230","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/eji.201141871","article-title":"Anti IL-17A therapy inhibits bone loss in TNF-alpha-mediated murine arthritis by modulation of the T-cell balance","volume":"42","author":"Zwerina","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2021.155521_b0235","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1073\/pnas.89.9.4076","article-title":"Coordinated anti-inflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist","volume":"89","author":"Vannier","year":"1992","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.cyto.2021.155521_b0240","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1172\/JCI115872","article-title":"Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4","volume":"90","author":"Lacraz","year":"1992","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.cyto.2021.155521_b0245","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/jbmr.5650091005","article-title":"Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice","volume":"9","author":"Nakano","year":"1994","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.cyto.2021.155521_b0250","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/ar14","article-title":"Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis","volume":"1","author":"Joosten","year":"1999","journal-title":"Arthritis Res."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:59:40Z","timestamp":1760907580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":50,"alternative-id":["S1043466621001010"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155521","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine profile in patients with chronic non-bacterial osteomyelitis, juvenile idiopathic arthritis, and insulin-dependent diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155521"}}